Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Centers In Bc Article
This is a selection made from among articles on Drug Treatment Centers In Bc. For a permanent link to this article, or to bookmark it for future reading, click here.
Pros and Cons of Drug Testing Your Employees in the Workplace
from: Drug testing employees in the workplace can be a valuable tool in detecting and putting a stop to drug use. Now, without further adieu, here are the pros and cons of drug testing your employees in the workplace. Pros of Drug Testing in the Workplace
Increases Safety: Drug testing in the workplace can make the working environment a much safer place to be.
Reduces Accidents: It has been noted that those under the influence of illicit substances are more likely to cause or be apart of accidents in the workplace. By drug testing, you eliminate or greatly reduce the incidence of accidents on the job.
Helps Drug Abusers: Many drug abusers are addicted to substances and need help. By enforcing drug testing in the workplace, you can catch someone’s drug problem before they further hurt themselves or others.
Cons of Drug Testing in the Workplace
Invasion of Privacy: Random drug testing in the workplace allows an employer the option of requiring a person to submit to drug tests if they wish to keep their jobs. Some consider this requirement to be an invasion of personal privacy and to be discriminatory against employees.
Costly: Drug testing can be quite an expensive endeavor, especially if you have a large company.
Could Be Unconstitutional: Along with being an invasion of privacy, drug testing in the workplace may be unconstitutional. While no rulings have been made on the subject as of yet, many groups feel random drug testing violates an individuals personal rights and freedoms.
About Author
This article is prepared by Christy Berger who writes for TestCountry.com . You can find a longer version of this article at Pros and Cons of Drug Testing Your Employees in the Workplace. The main resource of this article is the white paper at Creating a Drug Testing Program .
Source: ArticleTrader.com
Drug Treatment Centers In Bc Specific links
Drug Treatment Centers In Bc News
Study: Fake malaria drugs common in Asia, Africa - BusinessWeek
Study: Fake malaria drugs common in Asia, Africa BusinessWeek Studies show the drugs are taking longer to work there, and experts fear the emerging resistance could eventually spread to Africa as has occurred previously with other malaria treatments that now are worthless against the disease. |
'Malaria Progress Threatened By Increasing Drug Resistance And Inadequate ... - Medical News Today
 New York Daily News | 'Malaria Progress Threatened By Increasing Drug Resistance And Inadequate ... Medical News Today Although there has been considerable progress made in malaria control over the past 10 years, these global efforts are now under threat due to increasing drug resistance and inadequate treatment. According to the researchers, approximately 42% of ... Fake malaria drugs common in Asia, Africa; Over 33% of the malaria drugs on ... |
Seattle Genetics Announces Health Canada Accepts ADCETRIS(R) New Drug ... - MarketWatch (press release)
Seattle Genetics Announces Health Canada Accepts ADCETRIS(R) New Drug ... MarketWatch (press release) ... HL and sALCL demonstrated a high objective response rate and manageable safety profile in heavily pre-treated patients," said Joseph M. Connors, MD, FRCPC, Clinical Director, Center for Lymphoid Cancer at BC Cancer Agency in Vancouver, Canada. |
InNexus leader develops new firm - AZ Central.com
InNexus leader develops new firm AZ Central.com He has been CEO of InNexus Biotechnology since 2006, but the drug developer's activities have wound down. Trading of the company's shares on the Toronto Stock Exchange was halted in November by Canadian stock-market regulators. |
Seattle Genetics Announces Health Canada Accepts ADCETRIS® New Drug Submission ... - Victoria Times Colonist
Seattle Genetics Announces Health Canada Accepts ADCETRIS® New Drug Submission ... Victoria Times Colonist ... HL and sALCL demonstrated a high objective response rate and manageable safety profile in heavily pre-treated patients,” said Joseph M. Connors, MD, FRCPC, Clinical Director, Center for Lymphoid Cancer at BC Cancer Agency in Vancouver, Canada. |
Reinventing Kalamazoo - The Deal Pipeline
Reinventing Kalamazoo The Deal Pipeline Likewise, Kalamazoo could have moved on from its past as a drug development center and endeavored to shift, like many other American cities, to services, marketing its pastoral landscape and hearty restaurants, or simply done nothing. |
Controversy around province's choice of stop-smoking drug - Victoria Times Colonist
Controversy around province's choice of stop-smoking drug Victoria Times Colonist By Cindy E. Harnett, Times Colonist May 12, 2012 As the BC government touts the popularity of its new smokingcessation program, which provides the stop-smoking pill Champix at no charge, a hearing to certify a class-action lawsuit against the drug's ... |
Tech Tour Day Eight: Kalamazoo, BC Shine - CBS Local
 CBS Local | Tech Tour Day Eight: Kalamazoo, BC Shine CBS Local So what's better about testing for drugs and other chemicals with oral fluids rather than urine? “It's quick, easy, simple, dignified, and no special facilities are needed,” Lemberg said. “And it's the most accurate drug testing you can get … |
Crizotinib, an ALK/MET Tyrosine Kinase Inhibitor for ALK-Positive NSCLC - Cancer Network
Crizotinib, an ALK/MET Tyrosine Kinase Inhibitor for ALK-Positive NSCLC Cancer Network ... APRN-BC, AOCN, is an oncology educator and nurse practitioner at Boston Medical Center, Boston, Massachusetts. She has published cancer-related books for patients and professionals, and is an author of the Oncology Nursing Drug Handbook. Treatment ... |
Tekmira Provides Corporate Update and Announces First Quarter 2012 Results - MarketWatch (press release)
Tekmira Provides Corporate Update and Announces First Quarter 2012 Results MarketWatch (press release) VANCOUVER, British Columbia, May 15, 2012 (GlobeNewswire via COMTEX) -- Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) (TOR:CA:TKM) , a leading developer of RNA interference (RNAi) therapeutics, announced today its financial and operating results ... |